Amferia
M├╢lndal
About Amferia
Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia’s core focus is preventive healthcare where the goal is to provide highly efficient anti-infective medical devices that can prevent bacterial infections including those caused by antibiotic resistant bacteria. Our dominant focus is within the wound care sector, producing preventive care wound patches for the pressing need to avoid antibiotic resistant skin infections. Amferia’s proprietary anti-infective technology is a result of several years of research from Chalmers University of Technology and is patent protected.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.6M
- Last round: Undisclosed (Dec 2025)
- Website: amferia.com
Industries & Categories
Biotechnology, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/amferia-5482 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.